Shots:

• ELYXYB (previously as DFN-15) is an oral solution formulated using a self-micro emulsifying drug delivery system helps in improving solubility and bioavailability of the drug leading for absorption
• The candidate demonstrated a rapid onset of actions important for suffering from acute migraine and resulted in efficacy with few AEs
• NSAIDs including ELYXYB can lead to increase the risk of bleeding events also co-morbid conditions such as coagulation disorders

Click here to read full press release/ article | Ref: Business Wire | Image: Twitter